Thymosin Alpha 1: Research history

Verified publication timeline

1. 1994Clinical applications of thymosin alpha-1.Study →
2. 2001Thymosin alpha-1.Study →
3. 2004Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.Study →
4. 2015Thymosin alpha-1 treatment in chronic hepatitis B.Study →
5. 2015Historical review of thymosin α 1 in infectious diseases.Study →
6. 2016Immune Modulation with Thymosin Alpha 1 Treatment.Study →
7. 2017Thymosin alpha 1 and HIV-1: recent advances and future perspectives.Study →
8. 2018Thymosin alpha 1 treatment for patients with sepsis.Study →
9. 2018Serum thymosin alpha 1 levels in normal and pathological conditions.Study →
10. 2020The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysisStudy →
11. 2021Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort StudyStudy →
12. 2021Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 PatientsStudy →
13. 2021Thymosin Alpha 1 Mitigates Cytokine Storm in Blood Cells From Coronavirus Disease 2019 PatientsStudy →
14. 2022Thymosin α-1 Reverses M2 Polarization of Tumor-Associated Macrophages during Efferocytosis.Study →
15. 2023The efficacy of thymosin alpha-1 therapy in moderate to critical COVID-19 patients: a systematic review, meta-analysis, and meta-regressionStudy →
16. 2023A Pilot Trial of Thymalfasin (Thymosin-α-1) to Treat Hospitalized Patients With Hypoxemia and Lymphocytopenia Due to Coronavirus Disease 2019 Infection.Study →
17. 2023Thymosin α-1 in cancer therapy: Immunoregulation and potential applications.Study →
18. 2025Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysisStudy →
19. 2025Aging and Thymosin Alpha-1.Study →
20. 2025The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double-blinded, randomised, placebo-controlled, phase 3 trial.Study →